期刊文献+

间皮素Mesothelin对大鼠胰岛结构形成和重塑作用的研究进展

The function of Mesothelin during rat islet architecture formation and remodeling
原文传递
导出
摘要 大鼠胰腺发育的过程分为以细胞增生、分化为主的早中期及以结构形成、功能完善为主的后期这两个阶段,后期涉及胚胎后期胰岛结构形成和生后胰岛结构重塑。而β细胞的功能完善需要多种细胞迁移和细胞间支持黏附因子的介导,其中表达于β细胞的间皮素(Mesothelin)对细胞间的信号识别以及相互黏附有重要的作用。Mesothelin也是胰腺癌等多种恶性肿瘤的细胞表面标记物。有关Mesothelin在大鼠胰岛结构形成和结构重塑过程中的作用及其与胰腺癌形成关系的作用正处于研究之中。 The development of pancreatic islets of rats is divided into two phases: the early-medium phase and the late one.Predominant features are cellular proliferation and differentiation while architectural formation in the early-medium phase.Functional achievement are developed during the late-medium phase.The structural formation occurs during the phase of late embryo and the structural remodeling dose after birth.It is believed that the functional achievement of β-cells is regulated by migration of many kinds of cells and adhesion molecules. Among them Mesothelin which is expressed on the surface of β-cells is very important for recognition of information of cells and cellular adhesion. Mesothelin is also the surface maker of many kinds of malignant cells such as the cells of pancreatic carcinoma. The roles and significances that Mesothelin played in the process for formation and structural remodeling of islets of rats and in the development of pancreatic carcinoma are in investigated.
出处 《现代生物医学进展》 CAS 2009年第19期3757-3759,3767,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金(No.30670781)
关键词 MESOTHELIN 胰岛结构形成 胰岛结构重塑 细胞迁移黏附 Mesothelin Islet formation Islet remodeling Cell migration and adhesion
  • 相关文献

参考文献30

  • 1Joel F. Habener, Daniel M. Kemp, Melissa K. Thomas: Minireview: Transcriptional regulation in pancreatic development [J]. Endocrinology, 2005,146: 1025-1034.
  • 2Habener JF, Kemp DM, Thomas MK. Transcriptional regulation in pancreatic development[J]. Endocrinology 2005; 146(3): 1025-1034.
  • 3Heinrich U,Maurer J,Mann W.Evidence for a possible NOS back-up system in the organ of Corti of the guinea pig [J]. Eur Arch Otorhinolaryngol, 2004,261 (3): 121-128.
  • 4Huang CY, Cheng WF, Lee CN, Su YN, Chien SC, Tzeng YL, Hsieh CY, Chert CA. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor[J]. Anticancer Res, 2006, 26(6C): 4721-4728.
  • 5Hung CF, Calizo R, Tsai YC, He L, Wu TC. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors[J]. Vaccine, 2007, 25(1): 127-135.
  • 6Kojima T, O h-eda M, Hattori K, et al. Molecular cloning and expression of megakaryocyte potentiating factor eDNA [J]. J Biol Chem, 1995, 270:21984-21990.
  • 7Gu GQ, Wells JM, DombkowskiD, et al. Global expression analysis of gene regulatory pathways during endocrine pancreatic development [J]. Development, 2004, 131:165-179.
  • 8Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers[J]. Proc Natl Acad Sci USA, 1996, 93:136-140.
  • 9Bera TK, Pastan I. Mesothelin is not required for normal mouse development or reproduction[J]. Mol Cell Biol, 2000, 20:2902-2906.
  • 10Rump A, Morikawa Y. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion [J]. J Biol Chcm, 2004, 279(10): 9190-9198.

二级参考文献8

  • 1Argani P,Iacobuzio-Donahue C,Ryu B,et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res,2001,:3862-3868.
  • 2Chang K,Pastan I. Molecular cloning of mesothelin,a differentiation antigen present on mesothelium,mesotheliomas,and ovarian cancers. Proc Natl Acad Sci USA,1996,3: 136-140.
  • 3Bera TK,Pastan I. Mesothelin is not required for normal mouse development or reproduction. Mol Cell Biol,2000,0:2902-2906.
  • 4Chang K,Pastan I,Willingham MC. Isolation and characterization of a monoclonal antibody,K1,reactive with ovarian cancers and normal mesothelium. Int J Cancer,1992,50:373-381.
  • 5Chowdhury PS,Viner JL,Beers R,et al. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc Natl Acad Sci USA,1998,95:669-674.
  • 6Hassan R,Viner JL,Wang QC,et al. Anti-tumor activity of K1-LysPE38QQR,an immunotoxin targeting mesothelin,a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J Immunother,2000,23:473-479.
  • 7Kojima T,Oh-eda M,Hattori K,et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem,1995,270:21984-21990.
  • 8Scholler N,Fu N,Yang Y,et al. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci USA,1999,96:11531-11536.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部